Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Merck
AstraZeneca
Harvard Business School
Dow
Mallinckrodt

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GADOBENATE DIMEGLUMINE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Gadobenate Dimeglumine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00323310 Safety and Efficacy of MultiHance in Pediatric Patients Terminated Bracco Diagnostics, Inc Phase 3 2006-04-01 The purpose of this study was to assess the safety and enhancing properties of the magnetic resonance imaging (MRI) contrast agent MultiHance in children aged 2 to 17 years having central nervous system (CNS) disorders.
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Lantheus Medical Imaging N/A 2011-07-01 The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01165892 Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar) Completed Washington University School of Medicine N/A 2011-07-01 The use of the contrast agent, Ablavar, will help with the diagnosis of pulmonary embolism in magnetic resonance imaging (MRI).
NCT01260636 Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries Completed Bracco Diagnostics, Inc Phase 3 2009-09-01 To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gadobenate Dimeglumine

Condition Name

Condition Name for Gadobenate Dimeglumine
Intervention Trials
Breast Cancer 1
Adult Giant Cell Glioblastoma 1
Ductal Carcinoma in Situ - Category 1
Adult Oligodendroglioma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gadobenate Dimeglumine
Intervention Trials
Nervous System Diseases 2
Central Nervous System Diseases 2
Medulloblastoma 1
Peripheral Arterial Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gadobenate Dimeglumine

Trials by Country

Trials by Country for Gadobenate Dimeglumine
Location Trials
United States 6
Belgium 1
Italy 1
Poland 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gadobenate Dimeglumine
Location Trials
California 2
Michigan 2
Wisconsin 1
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gadobenate Dimeglumine

Clinical Trial Phase

Clinical Trial Phase for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Phase 3 2
Phase 2 3
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gadobenate Dimeglumine
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Terminated 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gadobenate Dimeglumine

Sponsor Name

Sponsor Name for Gadobenate Dimeglumine
Sponsor Trials
Bracco Diagnostics, Inc 3
National Cancer Institute (NCI) 2
Andrew Ko 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gadobenate Dimeglumine
Sponsor Trials
Other 5
Industry 5
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Baxter
Dow
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.